691 related articles for article (PubMed ID: 7637479)
21. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
Alonso PL; Smith TA; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Hayes R; Hurt N; Font F; Menendez C; Kilama WL; Tanner M
J Infect Dis; 1996 Aug; 174(2):367-72. PubMed ID: 8699068
[TBL] [Abstract][Full Text] [Related]
22. The development of malaria vaccines: SPf66--what next?
Tanner M; Alonso PL
Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
[TBL] [Abstract][Full Text] [Related]
23. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
[TBL] [Abstract][Full Text] [Related]
24. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial.
Shankar AH; Genton B; Semba RD; Baisor M; Paino J; Tamja S; Adiguma T; Wu L; Rare L; Tielsch JM; Alpers MP; West KP
Lancet; 1999 Jul; 354(9174):203-9. PubMed ID: 10421302
[TBL] [Abstract][Full Text] [Related]
25. Malaria vaccines.
Amador R; Patarroyo ME
J Clin Immunol; 1996 Jul; 16(4):183-9. PubMed ID: 8840219
[TBL] [Abstract][Full Text] [Related]
26. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Aide P; Sigauque B; Milman J; Mandomando I; Bassat Q; Guinovart C; Espasa M; Corachan S; Lievens M; Navia MM; Dubois MC; Menendez C; Dubovsky F; Cohen J; Thompson R; Ballou WR
Lancet; 2005 Dec; 366(9502):2012-8. PubMed ID: 16338450
[TBL] [Abstract][Full Text] [Related]
27. The Gambian National Impregnated Bed Net Programme: evaluation of effectiveness by means of case-control studies.
D'Alessandro U; Olaleye B; Langerock P; Bennett S; Cham K; Cham B; Greenwood BM
Trans R Soc Trop Med Hyg; 1997; 91(6):638-42. PubMed ID: 9509168
[TBL] [Abstract][Full Text] [Related]
28. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design.
Alonso PL; Tanner M; Smith T; Hayes RJ; Schellenberg JA; Lopez MC; Bastos de Azevedo I; Menendez C; Lyimo E; Weiss N
Vaccine; 1994 Feb; 12(2):181-6. PubMed ID: 8147101
[TBL] [Abstract][Full Text] [Related]
29. Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonzo PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos De Azevedo I; Chongela J; Kobero S; Menendez C
Med Trop (Mars); 1995; 55(4 Suppl):41-6. PubMed ID: 8649265
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response to the anti-malaria vaccine SPf66 in the Colombian Atrato River region.
Lopera TM; Restrepo M; Blair S; García HI
Mem Inst Oswaldo Cruz; 1998; 93(4):495-500. PubMed ID: 9711340
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
32. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
Rosas JE; Pedraz JL; Hernández RM; Gascón AR; Igartua M; Guzmán F; Rodríguez R; Cortés J; Patarroyo ME
Vaccine; 2002 Mar; 20(13-14):1707-10. PubMed ID: 11906756
[TBL] [Abstract][Full Text] [Related]
33. Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.
Schellenberg DM; Acosta CJ; Galindo CM; Kahigwa E; Urassa H; Masanja H; Aponte JJ; Schellenberg JR; Fraser-Hurt N; Lwilla F; Menendez C; Mshinda H; Tanner M; Alonso PL
Trop Med Int Health; 1999 May; 4(5):377-82. PubMed ID: 10402974
[TBL] [Abstract][Full Text] [Related]
34. Vaccines for preventing malaria (SPf66).
Graves P; Gelband H
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005966. PubMed ID: 16625647
[TBL] [Abstract][Full Text] [Related]
35. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission.
Teuscher T; Schellenberg JR; Bastos de Azevedo I; Hurt N; Smith T; Hayes R; Masanja H; Silva Y; Lopez MC; Kitua A
Vaccine; 1994 Mar; 12(4):328-36. PubMed ID: 8178555
[TBL] [Abstract][Full Text] [Related]
36. A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.
Moorthy VS; Imoukhuede EB; Milligan P; Bojang K; Keating S; Kaye P; Pinder M; Gilbert SC; Walraven G; Greenwood BM; Hill AS
PLoS Med; 2004 Nov; 1(2):e33. PubMed ID: 15526058
[TBL] [Abstract][Full Text] [Related]
37. Seasonality and malaria in a west African village: does high parasite density predict fever incidence?
Bouvier P; Rougemont A; Breslow N; Doumbo O; Delley V; Dicko A; Diakite M; Mauris A; Robert CF
Am J Epidemiol; 1997 May; 145(9):850-7. PubMed ID: 9143216
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Milman J; Mandomando I; Spiessens B; Guinovart C; Espasa M; Bassat Q; Aide P; Ofori-Anyinam O; Navia MM; Corachan S; Ceuppens M; Dubois MC; Demoitié MA; Dubovsky F; Menéndez C; Tornieporth N; Ballou WR; Thompson R; Cohen J
Lancet; 2004 Oct 16-22; 364(9443):1411-20. PubMed ID: 15488216
[TBL] [Abstract][Full Text] [Related]
39. Malaria vaccine trials: the missing qualitative data.
Ferreira M
Immunol Cell Biol; 1996 Aug; 74(4):301-5. PubMed ID: 8872178
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.
Valero MV; Amador R; Aponte JJ; Narvaez A; Galindo C; Silva Y; Rosas J; Guzman F; Patarroyo ME
Vaccine; 1996 Oct; 14(15):1466-70. PubMed ID: 8994323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
